GHWP Chair Visits GenSure for In-Depth Exchange

On September 23, 2026, Dr. Muralitharan a/l Paramasu, Chair of the Global Harmonization Working Party (GHWP), and Dr. Tingting Xie, Executive Secretary-General of GHWP, visited GenSure Biotech Inc. Mr. Heming Zhang, General Manager of GenSure , warmly welcomed the delegation.

During the visit, the delegation toured GenSure’s exhibition hall, R&D center, and production facilities, gaining insights into the company’s IVD R&D, intelligent manufacturing, quality management, and global market development. Dr. Muralitharan a/l Paramasu spoke highly of GenSure’s innovation capabilities and comprehensive product portfolio, and particularly recognized the company’s rapid new product development and strong quality management capabilities.

Dr. Muralitharan a/l Paramasu also showed strong interest in GenSure’s product development and market presence in Malaysia, expressing his hope that more GenSure products could be introduced to the Malaysian market to support local healthcare needs. Both sides further exchanged views on medical device regulatory harmonization, IVD market access, and international regulatory cooperation.

Looking ahead, GenSure will continue to pursue innovation, quality, and regulatory compliance, while leveraging Malaysia as an important hub for its Southeast Asian expansion. The company will further strengthen cooperation with regulatory authorities and industry partners, exploring opportunities in product registration, technical  exchange, and other areas to advance international collaboration in the IVD industry.